Literature DB >> 28383671

Drug-induced liver injury in Oncology.

A D Ricart1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28383671     DOI: 10.1093/annonc/mdx158

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  6 in total

1.  A clinically relevant combination treatment with doxorubicin and cyclophosphamide does not induce hepatotoxicity in C57BL/6J mice.

Authors:  Satyanarayana R Pondugula; Julia M Salamat; Kodye L Abbott; Patrick C Flannery; Mohammed Majrashi; Mohammed Almaghrabi; Manoj Govindarajulu; Sindhu Ramesh; Maninder Sandey; Suneel K Onteru; Chen-Che J Huang; Yoshimi Iwaki; Kristina Gill; Natasha Narayanan; Edwin McElroy; Darshini Desai; Rishi Nadar; Timothy Moore; Muralikrishnan Dhanasekaran
Journal:  Liver Res       Date:  2021-05-07

2.  Ellagic Acid Resensitizes Gemcitabine-Resistant Bladder Cancer Cells by Inhibiting Epithelial-Mesenchymal Transition and Gemcitabine Transporters.

Authors:  Ying-Si Wu; Jar-Yi Ho; Cheng-Ping Yu; Chun-Jung Cho; Chia-Lun Wu; Cheng-Shuo Huang; Hong-Wei Gao; Dah-Shyong Yu
Journal:  Cancers (Basel)       Date:  2021-04-22       Impact factor: 6.639

Review 3.  Next-Generation DILI Biomarkers: Prioritization of Biomarkers for Qualification and Best Practices for Biospecimen Collection in Drug Development.

Authors:  Sharin E Roth; Mark I Avigan; David Bourdet; David Brott; Rachel Church; Ajit Dash; Douglas Keller; Philip Sherratt; Paul B Watkins; Lucas Westcott-Baker; Silvia Lentini; Michael Merz; Lila Ramaiah; Shashi K Ramaiah; Ann Marie Stanley; John Marcinak
Journal:  Clin Pharmacol Ther       Date:  2019-09-14       Impact factor: 6.875

4.  Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2.

Authors:  Masatoshi Kudo; Peter R Galle; Giovanni Brandi; Yoon-Koo Kang; Chia-Jui Yen; Richard S Finn; Josep M Llovet; Eric Assenat; Philippe Merle; Stephen L Chan; Daniel H Palmer; Masafumi Ikeda; Tatsuya Yamashita; Arndt Vogel; Yi-Hsiang Huang; Paolo B Abada; Reigetsu Yoshikawa; Kenta Shinozaki; Chunxiao Wang; Ryan C Widau; Andrew X Zhu
Journal:  JHEP Rep       Date:  2020-11-13

5.  Garlic Extract Alleviates Trastuzumab-Induced Hepatotoxicity in Rats Through Its Antioxidant, Anti-Inflammatory, and Antihyperlipidemic Effects.

Authors:  Ayman M Mousa; Khaled E A Soliman; Fahad Alhumaydhi; Ahmad Almatroudi; Osamah Al Rugaie; Khaled S Allemailem; Faris Alrumaihi; Arif Khan; Mohamad Y Rezk; Mohammad Aljasir; Ameen S S Alwashmi; Faris F Aba Alkhayl; Aqel S Albutti; Hanan S Seleem
Journal:  J Inflamm Res       Date:  2021-11-27

6.  Clinical implications of drug-induced liver injury in early-phase oncology clinical trials.

Authors:  Sebastian P Mondaca; Dazhi Liu; Jessica R Flynn; Sandy Badson; Stefan Hamaway; Mrinal M Gounder; Danny N Khalil; Alexander E Drilon; Bob T Li; Komal L Jhaveri; Alison M Schram; Katherine E Kargus; Mary Kate Kasler; Natalie M Blauvelt; Neil H Segal; Marinela Capanu; Margaret K Callahan; David M Hyman; Maya Gambarin-Gelwan; James J Harding
Journal:  Cancer       Date:  2020-08-18       Impact factor: 6.860

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.